Abraham Silji's Form 4 filing
West Pharmaceutical Services Inc (WST) · filed Aug 10, 2023
- Accession no.
- 0001562180-23-006276
- Filed
- Aug 10, 2023
- Trade date
- Aug 8, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.24M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Abraham SiljiCIK 0001733001 | Officer (SVP, Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2023 | Common Stock | MOption exerciseAcquired | +8,160 | $102.51 | +$836,481.6 | 12,369.3 | Direct | |
| Aug 8, 2023 | Common Stock | SSaleDisposed | −8,154 | $397.18 | −$3,238,605.72 | 4,215.3 | Direct | |
| Aug 8, 2023 | Common Stock | SSaleDisposed | −6 | $397.69 | −$2,386.14 | 4,209.3 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2023 | Common Stock | MOption exerciseDisposed | −8,160 | $102.51 | −$836,481.6 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.